Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 223 participants.
Also called NCT02280590
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 223 participants
- Sponsor
- Registry
-
NCT02280590
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- Not reported
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02280590. Randomized; no masking; primary purpose treatment. Start 2014-09 (registry gives no type); primary completion 2015-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia
- Condition
- Hyperlipidemia
- Intervention (Drug)
- Rosuvastatin(Cresnon®)
- Intervention (Drug)
- Rosuvastatin(Crestor®)
- Lead sponsor
- Dong-A ST Co., Ltd.
Record details
- Record id
cardio:ct-nct02280590- Content hash
f1b44d4d223ad1b4d2f92cd63c0d75aa59f6b88de6bf293ca531148ef47cc9d3